Your browser doesn't support javascript.
loading
Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo.
Edgar, Julia E; Trezise, Stephanie; Anthony, Robert M; Krammer, Florian; Palese, Peter; Ravetch, Jeffrey V; Bournazos, Stylianos.
Affiliation
  • Edgar JE; Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY 10065.
  • Trezise S; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129.
  • Anthony RM; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129.
  • Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Palese P; Center for Vaccine Research and Pandemic Preparedness, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Ravetch JV; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Bournazos S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Proc Natl Acad Sci U S A ; 120(44): e2314905120, 2023 Oct 31.
Article in En | MEDLINE | ID: mdl-37871218

Full text: 1 Database: MEDLINE Main subject: Orthomyxoviridae / Influenza Vaccines / Orthomyxoviridae Infections / Influenza, Human Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Orthomyxoviridae / Influenza Vaccines / Orthomyxoviridae Infections / Influenza, Human Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2023 Type: Article